|
DLEU2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.31859999988826E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.30140000284851E-08 |
| Normal-vs-Stage2 |
9.698500E-03 |
| Normal-vs-Stage3 |
1.236850E-04 |
| Normal-vs-Stage4 |
2.241800E-04 |
| Stage1-vs-Stage2 |
6.478200E-01 |
| Stage1-vs-Stage3 |
4.904800E-01 |
| Stage1-vs-Stage4 |
4.002800E-01 |
| Stage2-vs-Stage3 |
9.214000E-01 |
| Stage2-vs-Stage4 |
3.425200E-01 |
| Stage3-vs-Stage4 |
2.670800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88950000038035E-07 |
| Normal-vs-AfricanAmerican |
3.834200E-04 |
| Normal-vs-Asian |
3.917700E-03 |
| Caucasian-vs-AfricanAmerican |
3.992800E-01 |
| Caucasian-vs-Asian |
2.164200E-01 |
| AfricanAmerican-vs-Asian |
1.372390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96527999999363E-05 |
| Normal-vs-Female |
8.37710000034519E-07 |
| Male-vs-Female |
5.096200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.09109999923973E-08 |
| Normal-vs-Age(41-60Yrs) |
4.047100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.45309999996812E-06 |
| Normal-vs-Age(81-100Yrs) |
1.997170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.603000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.524000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.868230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.161900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.179600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.250000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.442400E-02 |
| Classical-VS-Follicular |
6.088200E-01 |
| Classical-VS-Other |
9.432400E-01 |
| Classical-VS-Normal |
1.48859999993256E-07 |
| Tall-VS-Follicular |
3.912100E-02 |
| Tall-VS-Other |
3.536800E-01 |
| Tall-VS-Normal |
1.376160E-02 |
| Follicular-VS-Other |
8.332200E-01 |
| Follicular-VS-Normal |
2.27090000000096E-05 |
| Other-VS-Normal |
5.034100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.184840E-04 |
| Normal-vs-N1 |
1.94800999999689E-05 |
| N0-vs-N1 |
3.918200E-02 |
|
|
